Form 4 for FWONA Liberty Media Corp

Accepted 2023-07-20 00:00:00 ET · period of report 2023-07-18 · accession 0001225208-23-007608 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2023-07-20	2023-07-18	FWONA	MAFFEI GREGORY B	Pres, CEO, Dir	J - Other	$0.00	-1.21M	0	-100%	$0
DM	2023-07-20	2023-07-18	FWONA	MAFFEI GREGORY B	Pres, CEO, Dir	J - Other	—	-1.10M	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#	Table	Security	Date	Code	A/D	Shares	Price	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Series C Liberty Braves Common Stock	2023-07-18	J	D	1,050,907	$0.00	D	—	—	(F1) On July 18, 2023, Liberty Media Corporation (the "Issuer") redeemed (the "Redemption") each share of its Liberty Braves common stock for shares of common stock of Atlanta Braves Holdings, Inc. ("Atlanta Braves Holdings"). In the Redemption, the Issuer redeemed (i) each outstanding share of its Series A Liberty Braves common stock for one share of Atlanta Braves Holdings' Series A common stock, (ii) each outstanding share of its Series B Liberty Braves common stock for one share of Atlanta Braves Holdings' Series B common stock and (iii) each outstanding share of its Series C Liberty Braves common stock for one share of Atlanta Braves Holdings' Series C common stock. Such transactions were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
2	Common	Series A Liberty Braves Common Stock	2023-07-18	J	D	150,687	$0.00	D	—	—	(F1) On July 18, 2023, Liberty Media Corporation (the "Issuer") redeemed (the "Redemption") each share of its Liberty Braves common stock for shares of common stock of Atlanta Braves Holdings, Inc. ("Atlanta Braves Holdings"). In the Redemption, the Issuer redeemed (i) each outstanding share of its Series A Liberty Braves common stock for one share of Atlanta Braves Holdings' Series A common stock, (ii) each outstanding share of its Series B Liberty Braves common stock for one share of Atlanta Braves Holdings' Series B common stock and (iii) each outstanding share of its Series C Liberty Braves common stock for one share of Atlanta Braves Holdings' Series C common stock. Such transactions were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
3	Common	Series B Liberty Braves Common Stock	2023-07-18	J	D	3,669	$0.00	D	—	—	(F2) Each share of Series B Liberty Braves common stock is convertible, at the holder's election, into one share of Series A Liberty Braves common stock, at any time for no consideration other than the surrender of the share of Series B Liberty Braves common stock for each share of Series A Liberty Braves common stock. (F1) On July 18, 2023, Liberty Media Corporation (the "Issuer") redeemed (the "Redemption") each share of its Liberty Braves common stock for shares of common stock of Atlanta Braves Holdings, Inc. ("Atlanta Braves Holdings"). In the Redemption, the Issuer redeemed (i) each outstanding share of its Series A Liberty Braves common stock for one share of Atlanta Braves Holdings' Series A common stock, (ii) each outstanding share of its Series B Liberty Braves common stock for one share of Atlanta Braves Holdings' Series B common stock and (iii) each outstanding share of its Series C Liberty Braves common stock for one share of Atlanta Braves Holdings' Series C common stock. Such transactions were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
4	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	352,224	—	D	$26.36 · 2024-12-31 to 2027-12-10	352,224 Series C Liberty Braves Common Stock	(F3) In connection with the Redemption, all option awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the option awards were granted, such that each Braves Award was exchanged for an option to purchase an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
5	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	313,342	—	D	$29.10 · 2023-12-31 to 2026-12-15	313,342 Series C Liberty Braves Common Stock	(F3) In connection with the Redemption, all option awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the option awards were granted, such that each Braves Award was exchanged for an option to purchase an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
6	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	136,528	—	D	$20.07 · 2020-12-31 to 2027-03-11	136,528 Series C Liberty Braves Common Stock	(F3) In connection with the Redemption, all option awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the option awards were granted, such that each Braves Award was exchanged for an option to purchase an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
7	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	46,052	—	D	$23.34 · 2018-12-31 to 2025-03-05	46,052 Series C Liberty Braves Common Stock	(F3) In connection with the Redemption, all option awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the option awards were granted, such that each Braves Award was exchanged for an option to purchase an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
8	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	133,594	—	D	$23.51 · 2017-12-31 to 2024-03-30	133,594 Series C Liberty Braves Common Stock	(F3) In connection with the Redemption, all option awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the option awards were granted, such that each Braves Award was exchanged for an option to purchase an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
9	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	94,859	—	D	$25.49 · 2022-12-30 to 2029-03-09	94,859 Series C Liberty Braves Common Stock	(F3) In connection with the Redemption, all option awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the option awards were granted, such that each Braves Award was exchanged for an option to purchase an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
10	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	15,283	—	D	$23.51 · 2017-03-30 to 2024-03-30	15,283 Series C Liberty Braves Common Stock	(F3) In connection with the Redemption, all option awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the option awards were granted, such that each Braves Award was exchanged for an option to purchase an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
11	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	6,908	—	D	$27.73 · 2019-03-06 to 2026-03-06	6,908 Series C Liberty Braves Common Stock	(F3) In connection with the Redemption, all option awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the option awards were granted, such that each Braves Award was exchanged for an option to purchase an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.